RxDoctor Payments DataLook up a doctor →

John Manchin, DO

Family Medicine · Farmington, WVNPI 1134231640

Payments from drug & device makers

$15,960in general payments, 2019–2025

Across 1,037 payments — averaging $15.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • AstraZeneca$2K
  • Novo Nordisk$2K
  • Amgen$950
  • Boehringer Ingelheim$929
  • Lilly USA, LLC$699
  • plus $7K from 52 others

What the payments were for

  • Food & beverage$15,76299%
  • Education$1981%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)209$2,699
AstraZeneca(2 entities)96$1,736
Novo Nordisk97$1,621
Amgen(2 entities)64$950
Boehringer Ingelheim61$929
Lilly USA, LLC43$699
Takeda Pharmaceuticals U.S.A., Inc.38$585
Astellas Pharma US Inc29$555
Amarin Pharma, Inc.48$460
GSK32$410
Exact Sciences23$402
Merck34$380
Johnson & Johnson(2 entities)18$374
Pfizer25$368
Shield Therapeutics Inc11$334
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC22$300
Bayer17$252
Sunovion Pharmaceuticals Inc.15$245
Novartis16$229
Sanofi-aventis U.S. LLC16$224
Kowa Pharmaceuticals America, Inc.13$210
Abbott8$141
Eisai Inc.9$140
Phathom Pharmaceuticals, Inc.8$136
Currax Pharmaceuticals LLC8$116
Paratek Pharmaceuticals, Inc.5$104
Esperion Therapeutics, Inc.5$102
Redhill Biopharma Inc.5$87
Mylan Specialty L.p.5$86
Teva Pharmaceuticals USA, Inc.4$85
Dexcom, Inc.5$84
Biohaven Pharmaceuticals, Inc.4$83
Almatica Pharma LLC4$80
IBSA Pharma Inc.4$71
E.r. Squibb & Sons, L.L.C.4$66
Stryker1$61
Xeris Pharmaceuticals, Inc.3$57
Kyowa Kirin, Inc.2$46
Boston Scientific2$42
Ironwood Pharmaceuticals, Inc2$36
Biohaven Pharmaceutical Holding Company Ltd.2$34
ARS Pharmaceuticals Operations, Inc.2$33
Supernus Pharmaceuticals, Inc.2$28
Medtronic(2 entities)2$28
Insulet Corporation1$23
Ironshore Pharmaceuticals Inc.1$23
Viatris Specialty LLC1$22
Tandem Diabetes Care, Inc.1$21
Lundbeck LLC1$21
UCB, Inc.1$20
Tanabe Pharma America, Inc.1$18
Collegium Pharmaceutical, Inc.1$18
Tonix Medicines, Inc.1$17
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$16
Actelion Pharmaceuticals US, Inc.1$14
Optos, Inc.1$14
Si-bone, Inc.1$14
Genentech USA, Inc.1$11

How this compares

$15,960 in reported general payments places this provider in the 95th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$357,369
Medicare patients
756
Services billed
49,445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide271$287,144
EliquisApixaban198$165,095
JardianceEmpagliflozin133$110,313
TrulicityDulaglutide68$79,129
MounjaroTirzepatide61$63,243
JanuviaSitagliptin Phosphate62$59,331
Trelegy ElliptaFluticasone/Umeclidin/Vilanter51$54,019
VascepaIcosapent Ethyl69$47,457
XareltoRivaroxaban55$47,150
LinzessLinaclotide59$43,099
Repatha SureclickEvolocumab44$34,032
RybelsusSemaglutide27$33,095
FarxigaDapagliflozin Propanediol46$32,892
Breztri AerosphereBudesonide/Glycopyr/Formoterol31$26,596
CreonLipase/Protease/Amylase14$25,250

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,621$320,239298 claims
PfizerEliquis$368$165,095198 claims
Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat, Glyxambi, Spiriva Respimat$929$163,997198 claims
Lilly USA, LLCTrulicity, Mounjaro$699$142,372129 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$1,736$76,563147 claims
MerckJanuvia, Janumet$380$68,71276 claims
AbbVieLinzess, Creon$2,699$68,34973 claims
GSKTrelegy Ellipta$410$54,01951 claims
Johnson & JohnsonXarelto$374$47,15055 claims
Astellas Pharma US IncMyrbetriq$555$25,13840 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Farmington

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →